In a recent study, a research team developed a novel method to synthesize multifunctional composite particles. These ...

JPMorgan lowered the firm’s price target on Ionis Pharmaceuticals (IONS) to $45 from $47 and keeps a Neutral rating on the shares. The firm ...

A team of researchers working on water purification unexpectedly uncovered a breakthrough method for isolating lithium-6, a ...

Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

As the world makes more use of renewable energy sources, new battery technology is needed to store electricity for the times ...

After hours: March 21 at 4:14:44 PM EDT Loading Chart for IONS ...

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a ...

To mitigate global climate change, emissions of the primary culprit, carbon dioxide, must be drastically reduced. A newly ...

Electrochemical devices like batteries and fuel cells help power our modern lives. These devices traditionally contain a ...

Scientists have discovered a mercury-free method to isolate lithium-6, a vital ingredient in nuclear fusion fuel. The ...